港股异动 | 天星医疗(01609)盘中一度涨超36% 近期取得欧盟MDR认证及多个海外市场产品注册批准

智通财经网

12 hours ago

智通财经APP获悉，天星医疗(01609)盘中一度涨超36%，截至发稿，涨12.66%，报113港元，成交额7116.53万港元。

消息面上，天星医疗发布公告，近期，本公司收到欧盟医疗器械新规(CE MDR)认证证书，为中国第一家全线产品获得CE MDR认证的运动医学厂商。前述证书涉及产品包括全缝线锚钉、全缝线袢板、连续缝合多针半月板、金属带线锚钉、聚醚醚酮带线锚钉、碳纤维复合带线锚钉等15类产品，上述产品包括了植入物、有源设备及耗材和内窥镜手术器械，可以为肩、膝、髋、肘、手腕、足踝六大关节提供整体临床解决方案。

同时，本公司于英国、澳大利亚、巴西、新加坡、马来西亚、泰国等国家提交的等离子手术设备及电极、全缝线锚钉、缝线类产品等产品注册申请已相继获得批准，并取得当地主管当局颁发的注册证书。上述认证证书及注册证书的取得，标志着本公司更多产品符合欧盟及上述国家的法规要求，有利于本公司进一步拓展欧盟、拉丁美洲、东南亚的海外业务布局，进一步增强本公司在国际市场的竞争力和产品布局。

更多港股重磅资讯，下载智通财经app

更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2667634917"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2667634917\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2667634917?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-09-14 10:56","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2667634917","market":"fut","top_or_hot":-1,"title":"港股异动 | 天星医疗(01609)盘中一度涨超36% 近期取得欧盟MDR认证及多个海外市场产品注册批准","media":"智通财经网","content":"<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/01609\">天星医疗</a>(01609)盘中一度涨超36%，截至发稿，涨12.66%，报113港元，成交额7116.53万港元。</p><p>消息面上，天星医疗发布公告，近期，本公司收到欧盟医疗器械新规(CE MDR)认证证书，为中国第一家全线产品获得CE MDR认证的运动医学厂商。前述证书涉及产品包括全缝线锚钉、全缝线袢板、连续缝合多针半月板、金属带线锚钉、聚醚醚酮带线锚钉、碳纤维复合带线锚钉等15类产品，上述产品包括了植入物、有源设备及耗材和内窥镜手术器械，可以为肩、膝、髋、肘、手腕、足踝六大关节提供整体临床解决方案。</p><p>同时，本公司于英国、澳大利亚、巴西、新加坡、马来西亚、泰国等国家提交的等离子手术设备及电极、全缝线锚钉、缝线类产品等产品注册申请已相继获得批准，并取得当地主管当局颁发的注册证书。上述认证证书及注册证书的取得，标志着本公司更多产品符合欧盟及上述国家的法规要求，有利于本公司进一步拓展欧盟、拉丁美洲、东南亚的海外业务布局，进一步增强本公司在国际市场的竞争力和产品布局。</p><p>更多港股重磅资讯，下载智通财经app</p><p>更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)</p> </body></html>","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 天星医疗(01609)盘中一度涨超36% 近期取得欧盟MDR认证及多个海外市场产品注册批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 天星医疗(01609)盘中一度涨超36% 近期取得欧盟MDR认证及多个海外市场产品注册批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-14 10:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1495483.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，天星医疗(01609)盘中一度涨超36%，截至发稿，涨12.66%，报113港元，成交额7116.53万港元。消息面上，天星医疗发布公告，近期，本公司收到欧盟医疗器械新规(CE MDR)认证证书，为中国第一家全线产品获得CE MDR认证的运动医学厂商。前述证书涉及产品包括全缝线锚钉、全缝线袢板、连续缝合多针半月板、金属带线锚钉、聚醚醚酮带线锚钉、碳纤维复合带线锚钉等15类产品，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1495483.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1495483.html","article_id":"2667634917","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2667634917","pubTimestamp":1789354572,"columns":[],"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，天星医疗盘中一度涨超36%，截至发稿，涨12.66%，报113港元，成交额7116.53万港元。消息面上，天星医疗发布公告，近期，本公司收到欧盟医疗器械新规认证证书，为中国第一家全线产品获得CE MDR认证的运动医学厂商。上述认证证书及注册证书的取得，标志着本公司更多产品符合欧盟及上述国家的法规要求，有利于本公司进一步拓展欧盟、拉丁美洲、东南亚的海外业务布局，进一步增强本公司在国际市场的竞争力和产品布局。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1100":"医疗保健设备","A27.SI":"MDR LIMITED","BK4588":"碎股","BK1148":"建筑与工程","BK4585":"ETF&股票定投概念","BK6057":"技术产品经销商","Y3D.SI":"MDR Limited","VXUS":"国际股票ETF-Vanguard","KCAI":"KraneShares China Alpha Index ETF","01609":"天星医疗"},"translate_title":"Hong Kong Stocks in Focus | Tianxing Medical (01609) surged over 36% at one point during trading after recently obtaining EU MDR certification and product registration approvals in several overseas markets.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01609":1.5,"KCAI":1.5,"A27.SI":1.5,"FSXEmain":1.5,"VXUS":1.5,"FESXmain":1.5,"Y3D.SI":1.5},"content_text":"智通财经APP获悉，天星医疗(01609)盘中一度涨超36%，截至发稿，涨12.66%，报113港元，成交额7116.53万港元。消息面上，天星医疗发布公告，近期，本公司收到欧盟医疗器械新规(CE MDR)认证证书，为中国第一家全线产品获得CE MDR认证的运动医学厂商。前述证书涉及产品包括全缝线锚钉、全缝线袢板、连续缝合多针半月板、金属带线锚钉、聚醚醚酮带线锚钉、碳纤维复合带线锚钉等15类产品，上述产品包括了植入物、有源设备及耗材和内窥镜手术器械，可以为肩、膝、髋、肘、手腕、足踝六大关节提供整体临床解决方案。同时，本公司于英国、澳大利亚、巴西、新加坡、马来西亚、泰国等国家提交的等离子手术设备及电极、全缝线锚钉、缝线类产品等产品注册申请已相继获得批准，并取得当地主管当局颁发的注册证书。上述认证证书及注册证书的取得，标志着本公司更多产品符合欧盟及上述国家的法规要求，有利于本公司进一步拓展欧盟、拉丁美洲、东南亚的海外业务布局，进一步增强本公司在国际市场的竞争力和产品布局。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}